SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.140+1.8%9:43 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BoredMember who wrote (10200)5/8/2018 2:38:43 PM
From: drkaz  Read Replies (2) of 12873
 
You chose to continue to miss the point. I will not regard NNVC as a successful business until there is a product working its way toward market. We are decidedly not obviously working our way toward having a product on the market at present.

The biotech market does not view, and will not view, NNVC as a successful business until there is a product working its way toward market.

You, unless you own a piece of TheraCour, should probably also not consider NNVC to be a successful business to date. As Dr. Diwan definitely owns a piece of TheraCour, he should definitely view NNVC as a success for him personally to this point. It has provided him a steady and reliable income to do the R&D that he currently is profiting from, and that - yes - he might profit even more handsomely from if/when NNVC is a successful, revenue-generating business.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News